Back to GetFilings.com



Table of Contents

 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

 
FORM 10-Q
 
x
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2002
 
COMMISSION FILE NO. 000-23087
 

 
AMERIGROUP CORPORATION
 
4425 Corporation Lane
Virginia Beach, VA 23462
(757) 490-6900
 
Delaware
 
54-1739323
(State or Other Jurisdiction of
Incorporation or Organization)
 
(I.R.S. Employer
Identification No.)
 

 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
 
As of July 31, 2002, there were 20,299,062 shares outstanding of AMERIGROUP’S common stock, par value $0.01.
 


Table of Contents
AMERIGROUP CORPORATION AND SUBSIDIARIES
 
TABLE OF CONTENTS
 
PART I.    FINANCIAL INFORMATION
 
Item 1.
     
3
       
4
       
5
       
6
Item 2.
     
9
Item 3.
     
13
    
PART II.    OTHER INFORMATION
    
Item 1.
     
14
Item 2.
     
14
Item 3.
     
14
Item 4.
     
14
Item 5.
     
14
Item 6.
     
15

2


Table of Contents
PART I.    FINANCIAL INFORMATION
 
Item 1.    Financial Statements
 
AMERIGROUP CORPORATION AND SUBSIDIARIES
 
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
 
    
June 30,
2002

    
December 31, 2001

 
    
(unaudited)
    
(note)
 
ASSETS
                 
Current assets:
                 
Cash and cash equivalents
  
$
160,349
 
  
$
183,900
 
Short-term investments
  
 
74,464
 
  
 
55,230
 
Premium receivables
  
 
37,670
 
  
 
29,301
 
Deferred income taxes
  
 
4,799
 
  
 
4,518
 
Prepaid expenses and other current assets
  
 
6,697
 
  
 
7,416
 
    


  


Total current assets
  
 
283,979
 
  
 
280,365
 
Property and equipment, net of accumulated depreciation of $12,950 and $9,845 at June 30, 2002 and December 31, 2001, respectively
  
 
17,989
 
  
 
15,014
 
Software, net of accumulated amortization of $7,383 and $4,738 at June 30, 2002 and December 31, 2001, respectively
  
 
10,128
 
  
 
9,581
 
Goodwill
  
 
25,930
 
  
 
19,407
 
Long-term investments
  
 
72,054
 
  
 
62,707
 
Investments on deposit for licensure
  
 
29,559
 
  
 
18,501
 
Deferred income taxes and other long-term assets
  
 
2,179
 
  
 
1,367
 
    


  


    
$
441,818
 
  
$
406,942
 
    


  


LIABILITIES AND STOCKHOLDERS’ EQUITY
                 
Current liabilities:
                 
Claims payable
  
$
187,761
 
  
$
180,346
 
Accounts payable
  
 
2,852
 
  
 
6,295
 
Accrued expenses and other current liabilities
  
 
36,192
 
  
 
33,918
 
    


  


Total current liabilities
  
 
226,805
 
  
 
220,559
 
Deferred income taxes and other long-term liabilities
  
 
5,569
 
  
 
2,867
 
    


  


Total liabilities
  
 
232,374
 
  
 
223,426
 
    


  


Stockholders’ equity:
                 
Common stock, $.01 par value. Authorized 60,000,000 shares; issued and outstanding 20,259,318 and 19,851,690 at June 30, 2002 and December 31, 2001, respectively
  
 
211
 
  
 
207
 
Additional paid-in capital
  
 
171,610
 
  
 
168,668
 
Retained earnings
  
 
38,218
 
  
 
15,416
 
Deferred compensation
  
 
(595
)
  
 
(775
)
    


  


Total stockholders’ equity
  
 
209,444
 
  
 
183,516
 
    


  


    
$
441,818
 
  
$
406,942
 
    


  



Note:
 
The balance sheet at December 31, 2001 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.
 
See accompanying notes to condensed consolidated financial statements.

3


Table of Contents
AMERIGROUP CORPORATION AND SUBSIDIARIES
 
CONDENSED CONSOLIDATED INCOME STATEMENTS
(Unaudited, dollars in thousands, except for per share data)
 
    
Three months
ended June 30,

    
Six months
ended June 30,

 
    
2002

    
2001

    
2002

    
2001

 
Revenues:
                                   
Premium
  
$
276,821
 
  
$
209,145
 
  
$
547,663
 
  
$
394,830
 
Investment income
  
 
2,054
 
  
 
2,784
 
  
 
4,060
 
  
 
6,105
 
    


  


  


  


Total revenues
  
 
278,875
 
  
 
211,929
 
  
 
551,723
 
  
 
400,935
 
    


  


  


  


Expenses:
                                   
Health benefits
  
 
221,481
 
  
 
163,703
 
  
 
444,482
 
  
 
314,395
 
Selling, general and administrative
  
 
32,318
 
  
 
28,112
 
  
 
62,239
 
  
 
52,210
 
Depreciation and amortization
  
 
3,231
 
  
 
2,286
 
  
 
5,985
 
  
 
4,323
 
Interest
  
 
183
 
  
 
234
 
  
 
369
 
  
 
412
 
    


  


  


  


Total expenses
  
 
257,213
 
  
 
194,335
 
  
 
513,075
 
  
 
371,340
 
    


  


  


  


Income before income taxes
  
 
21,662
 
  
 
17,594
 
  
 
38,648
 
  
 
29,595
 
Income tax expense
  
 
(8,746
)
  
 
(7,510
)
  
 
(15,846
)
  
 
(12,430
)
    


  


  


  


Net income
  
 
12,916
 
  
 
10,084
 
  
 
22,802
 
  
 
17,165
 
Accretion of redeemable preferred stock dividends
  
 
—  
 
  
 
(1,822
)
  
 
—  
 
  
 
(3,642
)
    


  


  


  


Net income attributable to common stockholders
  
$
12,916
 
  
$
8,262
 
  
$
22,802
 
  
$
13,523
 
    


  


  


  


Net income per share:
                                   
Basic net income per share
  
$
0.64
 
  
$
7.97
 
  
$
1.14
 
  
$
13.26
 
    


  


  


  


Weighted average number of common shares outstanding
  
 
20,083,779
 
  
 
1,036,638
 
  
 
19,984,370
 
  
 
1,020,071
 
    


  


  


  


Diluted net income per share
  
$
0.60
 
  
$
0.61
 
  
$
1.07
 
  
$
1.03
 
    


  


  


  


Weighted average number of common shares and potential dilutive common shares outstanding
  
 
21,493,134
 
  
 
15,889,397
 
  
 
21,368,836
 
  
 
15,893,421
 
    


  


  


  


 
 
See accompanying notes to condensed consolidated financial statements.

4


Table of Contents
AMERIGROUP CORPORATION AND SUBSIDIARIES
 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, dollars in thousands)
 
    
Three months
ended June 30,

    
Six months
ended June 30,

 
    
2002

    
2001

    
2002

    
2001

 
Cash flows from operating activities:
                                   
Net income
  
$
12,916
 
  
$
10,084
 
  
$
22,802
 
  
$
17,165
 
Adjustments to reconcile net income to net cash provided by operating activities:
                                   
Depreciation and amortization
  
 
3,231
 
  
 
2,286
 
  
 
5,985
 
  
 
4,323
 
Deferred tax expense (benefit)
  
 
(24
)
  
 
(810
)
  
 
858
 
  
 
(425
)
Amortization of deferred compensation
  
 
90
 
  
 
90
 
  
 
180
 
  
 
180
 
Changes in assets and liabilities increasing (decreasing) cash flows from operations:
                                   
Premium receivables
  
 
160
 
  
 
(7,036
)
  
 
(8,369
)
  
 
(11,178
)
Prepaid expenses and other current assets
  
 
(426
)
  
 
(309
)
  
 
719
 
  
 
1,581
 
Other assets
  
 
758
 
  
 
20
 
  
 
(930
)
  
 
13
 
Claims payable
  
 
(1,801
)
  
 
3,818
 
  
 
7,415
 
  
 
12,126
 
Accounts payable, accrued expenses and other current liabilities
  
 
6,182
 
  
 
5,218
 
  
 
2,097
 
  
 
2,461
 
Other long-term liabilities
  
 
(945
)
  
 
—  
 
  
 
618
 
  
 
—  
 
    


  


  


  


Net cash provided by operating activities
  
 
20,141
 
  
 
13,361
 
  
 
31,375
 
  
 
26,246
 
    


  


  


  


Cash flows from investing activities:
                                   
Proceeds from redemption of held-to-maturity securities
  
 
52,868
 
  
 
20,625
 
  
 
105,054
 
  
 
57,675
 
Purchase of held-to-maturity investments
  
 
(15,723
)
  
 
(54,863
)
  
 
(144,135
)
  
 
(80,096
)
Purchase of property, equipment and software
  
 
(3,428
)
  
 
(814
)
  
 
(6,255
)
  
 
(2,924
)
Proceeds from redemption of investments on deposit for licensure
  
 
1,130
 
  
 
9,021
 
  
 
6,736
 
  
 
15,009
 
Purchase of investments on deposit for licensure
  
 
(1,705
)
  
 
(13,225
)
  
 
(7,294
)
  
 
(20,726
)
Purchase of contract rights and related assets
  
 
(6,523
)
  
 
—  
 
  
 
(6,523
)
  
 
—  
 
    


  


  


  


Net cash provided by (used in) investing activities
  
 
26,619
 
  
 
(39,256
)
  
 
(52,417
)
  
 
(31,062
)
    


  


  


  


Cash flows from financing activities:
                                   
Payment of capital lease obligations
  
$
(699
)
  
$
(368
)
  
$
(1,183
)
  
$
(444
)
Payment of debt
  
 
—  
 
  
 
(500
)
  
 
—  
 
  
 
(1,000
)
Proceeds from exercise of common stock options and change in bank overdrafts
  
 
328
 
  
 
(260
)
  
 
(1,326
)
  
 
(294
)
    


  


  


  


Net cash used in financing activities
  
 
(371
)
  
 
(1,128
)
  
 
(2,509
)
  
 
(1,738
)
    


  


  


  


Net increase (decrease) in cash and cash equivalents
  
 
46,389
 
  
 
(27,023
)
  
 
(23,551
)
  
 
(6,554
)
Cash and cash equivalents at beginning of period
  
 
113,960
 
  
 
153,131
 
  
 
183,900
 
  
 
132,662
 
                                     
Cash and cash equivalents at end of period
  
$
  160,349
 
  
$
  126,108
 
  
$
160,349
 
  
$
  126,108
 
    


  


  


  


                                     
Supplemental disclosures of cash flow information:
                                   
Cash paid for interest
  
$
107
 
  
$
245
 
  
$
293
 
  
$
433
 
    


  


  


  


Cash paid for income taxes
  
$
8,388
 
  
$
7,989
 
  
$
8,775
 
  
$
7,989
 
    


  


  


  


Supplemental disclosures of non-cash activities:
                                   
Property and equipment acquired under capital lease
  
$
2,736
 
  
$
1,679
 
  
$
3,135
 
  
$
4,170
 
    


  


  


  


 
See accompanying notes to condensed consolidated financial statements.

5


Table of Contents
AMERIGROUP CORPORATION AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
 
1.    The accompanying condensed consolidated financial statements of AMERIGROUP Corporation and subsidiaries have been prepared without audit. In our opinion, they include all normal recurring adjustments necessary for a fair presentation of the results of operations for the three and six month periods ended June 30, 2002 and 2001 in accordance with the rules and regulations of the Securities and Exchange Commission. Although certain information and footnote disclosures normally included in financial statements presented in accordance with generally accepted accounting principles have been condensed or omitted, we believe the disclosures made are adequate to make the information presented not misleading. However, the condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 12, 2002. The results of operations for the three and six month periods ended June 30, 2002 are not necessarily indicative of the results for a full year because of the impact of seasonal and short-term variations.
 
On June 30, 2000, our Board of Directors and our stockholders approved a one-for-two reverse stock split of our common stock which was effected on November 9, 2001 in connection with the closing of the initial public offering. All agreements concerning stock options and warrants to purchase common stock provide for adjustments in the number of options or warrants and the related exercise price in the event of the declaration of a reverse stock split. All references to number of shares, except shares authorized, to common stock per share information, except par value per share and to stock options and warrants to purchase common stock in the condensed consolidated financial statements have been restated to reflect the stock split on a retroactive basis.
 
On November 9, 2001, we completed our initial public offering of 4,985,000 shares of common stock including an over-allotment issuance of 585,000 shares at a price per share of $17.00. We received net proceeds from the offering of approximately $77.2 million. In conjunction with the offering, all Series A, B, C and D preferred stock in the aggregate was converted into 12,607,880 shares of common stock. We used proceeds from the offering to repay the balance of our long-term debt facility of approximately $4.4 million and to redeem the Series E mandatorily redeemable preferred stock for approximately $13.3 million. In addition, 1,123,823 shares of common stock were issued upon the exercise of all outstanding Series E warrants.

6


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 
2.    Basic earnings per common share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding. Diluted earnings per common share is computed by dividing net income attributable to common stockholders plus the accretion of convertible preferred stock dividends by the weighted average number of shares of common stock outstanding plus other potentially dilutive securities. The following table sets forth the calculation of basic and diluted net income per share (dollars in thousands, except per share data):
 
    
For the Three months
ended June 30,

  
For the Six months
ended June 30,

    
2002

  
2001

  
2002

  
2001

Basic net income per share:
                           
Net income attributable to common stockholders
  
$
12,916
  
$
8,262
  
$
22,802
  
$
13,523
    

  

  

  

Weighted average number of common shares outstanding
  
 
20,083,779
  
 
1,036,638
  
 
19,984,370
  
 
1,020,071
    

  

  

  

Basic earnings per share
  
$
0.64
  
$
7.97
  
$
1.14
  
$
13.26
    

  

  

  

Diluted net income per share:
                           
Net income attributable to common stockholders
  
$
12,916
  
$
8,262
  
$
22,802
  
$
13,523
Plus: Accretion of convertible preferred stock dividends due to assumed conversion
  
 
—  
  
 
1,436
  
 
—  
  
 
2,870
    

  

  

  

Diluted net income attributable to common stockholders
  
$
12,916
  
$
9,698
  
$
22,802
  
$
16,393
    

  

  

  

Weighted average number of common shares outstanding
  
 
20,083,779
  
 
1,036,638
  
 
19,984,370
  
 
1,020,071
Dilutive effect of stock options and warrants (as determined by applying the treasury stock method) and convertible preferred stock
  
 
1,409,355
  
 
14,852,759
  
 
1,384,466
  
 
14,873,350
    

  

  

  

Weighted average number of common shares and potential dilutive common shares outstanding
  
 
21,493,134
  
 
15,889,397
  
 
21,368,836
  
 
15,893,421
    

  

  

  

Diluted earnings per share
  
$
0.60
  
$
0.61
  
$
1.07
  
$
1.03
    

  

  

  

 
As of June 30, 2002, we had 2,581,511 options outstanding with a weighted average exercise price of $13.71.
 
3.    Effective January 1, 2002, we purchased MethodistCare, Inc.’s (MethodistCare) Houston, Texas Medicaid line of business for approximately $1.6 million. The assets purchased consisted of MethodistCare’s rights to provide managed care services to its Medicaid members, as well as certain provider agreements.
 
4.    Effective July 1, 2002, we purchased Capital Community Health Plan’s (CCHP) Washington, D.C. Medicaid line of business. The assets purchased consisted of CCHP’s rights to provide managed care services to its Medicaid members, as well as certain provider agreements. In June 2002, approximately $6.8 million was placed in escrow for the acquisition.
 
5.    In July 2002, we expanded the Credit and Guaranty Agreement entered into in November 2001 to include a fourth bank and to increase the revolving credit facility to $75 million from $60 million. The facility is secured by the assets of AMERIGROUP Corporation and by the common stock of its wholly owned subsidiaries.

7


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 
6.    In July 2001, Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets (SFAS No. 142), was issued which requires that goodwill and intangible assets with indefinite useful lives no longer be amortized, but instead be tested annually for impairment. We have adopted SFAS No. 142 and have determined that our goodwill and other intangible assets are not impaired.
 
The following table presents net income and earnings per share exclusive of goodwill amortization expense for the three and six months ended June 30, 2002 and 2001 (dollars in thousands, except per share data):
 
    
Three months ended June 30,

  
Six months ended June 30,

    
2002

  
2001

  
2002

  
2001

Net income:
                           
Reported net income
  
$
12,916
  
$
10,084
  
$
22,802
  
$
17,165
Goodwill amortization, net of tax effect
  
 
—  
  
 
150
  
 
—  
  
 
300
    

  

  

  

Adjusted net income
  
$
12,916
  
$
10,234
  
$
22,802
  
$
17,465
    

  

  

  

Basic net income per share:
                           
Reported basic earnings per share
  
$
0.64
  
$
7.97
  
$
1.14
  
$
13.26
Goodwill amortization per basic share
  
 
—  
  
 
0.14
  
 
—  
  
 
0.29
    

  

  

  

Adjusted basic earnings per share
  
$
0.64
  
$
8.11
  
$
1.14
  
$
13.55
    

  

  

  

Diluted net income per share:
                           
Reported diluted earnings per share
  
$
0.60
  
$
0.61
  
$
1.07
  
$
1.03
Goodwill amortization per diluted share
  
 
—  
  
 
0.01
  
 
—  
  
 
0.02
    

  

  

  

Adjusted diluted earnings per share
  
$
0.60
  
$
0.62
  
$
1.07
  
$
1.05
    

  

  

  

8


Table of Contents
 
 
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
Forward-looking Statements
 
This Quarterly Report on Form 10-Q, and other information we provide from time to time, contains certain “forward-looking” statements as that term is defined by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations or cash flows, our continued performance improvements, our ability to service our debt obligations, our ability to finance growth opportunities, our ability to respond to changes in government regulations and similar statements including, without limitation, those containing words such as “believes,” “anticipates,” “expects,” “may,” “will,” “should,” “estimates,” “intends,” “plans,” and other similar expressions are forward-looking statements.
 
Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements as a result of, but not limited to, the following factors:
 
 
 
national, state and local economic conditions, including their effect on the rate setting process, timing of payments, as well as their effect on the availability and cost of labor, utilities and materials;
 
 
 
the effect of government regulations and changes in regulations governing the health care industry, including our compliance with such regulations and their effect on certain of our unit costs and our ability to manage our medical costs;
 
 
 
changes in Medicaid payment levels and methodologies and the application of such methodologies by the government;
 
 
 
liabilities and other claims asserted against the company;
 
 
 
our ability to attract and retain qualified personnel;
 
 
 
our ability to maintain compliance with all minimum capital requirements;
 
 
 
the availability and terms of capital to fund acquisitions and capital improvements;
 
 
 
the competitive environment in which we operate;
 
 
 
our ability to maintain and increase membership levels; and
 
 
 
demographic changes.
 
Investors should also refer to our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 12, 2002 for a discussion of risk factors. Given these risks and uncertainties, we can give no assurances that any forward-looking statements will, in fact, transpire and therefore caution investors not to place undue reliance on them.
 
Overview
 
We are a multi-state managed health care company focused on serving people who receive health care benefits through state-sponsored programs, including Medicaid, State Children’s Health Insurance Program (SCHIP) and FamilyCare. We were founded in December 1994 with the objective to become the leading managed care organization in the United States focused on serving people who receive these types of benefits. Our revenue is generated primarily from premiums received from the states in which we operate for providing health care benefits to members. We also generate revenues from investments. We generally receive a fixed premium per member per month to provide health care benefits to our members pursuant to contracts with four states and the District of Columbia. Our premiums are generally received in advance of providing services and we recognize premium revenue during the period in which we are obligated to provide services.

9


Table of Contents
 
The number of members we serve has increased since December 2001. The following table sets forth the approximate number of members we serve in each of our service areas for the periods presented.
 
    
June

    
Market

  
2002

    
2001

  
December 2001

Houston
  
128,000
 
  
71,000
  
100,000
Dallas
  
75,000
 
  
53,000
  
64,000
Fort Worth
  
63,000
 
  
46,000
  
50,000
New Jersey
  
97,000
 
  
72,000
  
88,000
Maryland
  
124,000
 
  
124,000
  
118,000
District of Columbia
  
13,000
 
  
13,000
  
13,000
Illinois
  
33,000
 
  
32,000
  
39,000
    

  
  
Total
  
533,000
 
  
411,000
  
472,000
    

  
  
Percentage growth from June 30, 2001 to June 30, 2002
  
29.7
%
         
 
The following table sets forth the approximate number of members we serve by our products for the periods presented.
 
    
June

    
Product

  
2002

  
2001

  
December 2001

AMERICAID (Medicaid—TANF)
  
338,000
  
265,000
  
294,000
AMERIKIDS (SCHIP)
  
123,000
  
92,000
  
112,000
AMERIPLUS (Medicaid—SSI)
  
45,000
  
37,000
  
43,000
AMERIFAM (FamilyCare)
  
27,000
  
17,000
  
23,000
    
  
  
Total
  
533,000
  
411,000
  
472,000
    
  
  
 
Results of Operations
 
The following table sets forth selected operating ratios. All ratios, with the exception of the health benefits ratio, are shown as a percentage of total revenues.
 
    
Three months ended June 30,

    
Six months
ended June 30,

 
    
2002

    
2001

    
2002

    
2001

 
Premium revenue
  
99.3
%
  
98.7
%
  
99.3
%
  
98.5
%
Investment income
  
0.7
 
  
1.3
 
  
0.7
 
  
1.5
 
    

  

  

  

Total revenues
  
100.0
%
  
100.0
%
  
100.0
%
  
100.0
%
    

  

  

  

Health benefits(1)
  
80.0
 
  
78.3
 
  
81.2
 
  
79.6
 
Selling, general and administrative expenses
  
11.6
 
  
13.3
 
  
11.3
 
  
13.0
 
Income before income taxes
  
7.8
 
  
8.3
 
  
7.0
 
  
7.4
 
Net income
  
4.6
 
  
4.8
 
  
4.1
 
  
4.3
 

(1)
 
The health benefits ratio is shown as a percentage of premium revenue because there is a direct relationship between the premium received and the health benefits provided.

10


Table of Contents
 
Three and Six Months Ended June 30, 2002 Compared to the Three and Six Months Ended June 30, 2001
 
Revenues
 
Premium revenue for the three months ended June 30, 2002 increased $67.7 million, or 32.4% to $276.8 million from $209.1 million for the three months ended June 30, 2001. Year-to-date premium revenue increased $152.9 million, or 38.7% to $547.7 million from $394.8 million in 2001. The increase was principally due to internal growth in overall membership and the acquisition of the Medicaid contracts and related assets of Humana’s Houston, Texas business in August 2001 (15,000 members) and MethodistCare Inc.’s Houston, Texas Medicaid contracts and related assets in January 2002 (11,000 members). Total membership increased 29.7% to 533,000 as of June 30, 2002 from 411,000 as of June 30, 2001.
 
Investment income decreased $0.7 million to $2.1 million for the three months ended June 30, 2002 and decreased $2.0 million to $4.1 million year-to-date. The decrease in investment income was primarily due to the continued decline in market interest rates and increased levels of investments in tax-advantaged securities partially offset by an increase in overall levels of cash and investments. Levels of cash and investments have primarily increased due to proceeds from our initial public offering, profitability and increases in the amount of premiums received versus the timing of the payment of the related health benefits.
 
Health benefits
 
Expenses relating to health benefits for the three months ended June 30, 2002 increased $57.8 million, or 35.3% to $221.5 million from $163.7 million for the three months ended June 30, 2001. Year-to-date, expenses related to health benefits increased $130.1 million, or 41.4%, to $444.5 million in 2002 from $314.4 million in 2001. The overall increase in health benefits expense was primarily due to the increase in membership. The health benefits ratio, as a percentage of premium revenue, for the three months ended June 30, 2002 increased to 80.0% from 78.3% for the three months ended June 30, 2001. Year-to-date, the health benefits ratio increased to 81.2% from 79.6% in 2001. The increase in the health benefits ratio as compared to the three and six months ended June 30, 2001, was primarily due to variations in levels of seasonality from 2001 to 2002 and changes in the mix of members by product.
 
Selling, general and administrative expenses
 
Selling, general and administrative expenses for the second quarter of 2002 increased $4.2 million to $32.3 million from $28.1 million for the three months ended June 30, 2001. Year-to-date, selling, general and administrative expenses increased $10.0 million to $62.2 million in 2002 from $52.2 million in 2001. The increase in selling, general and administrative expenses was primarily due to an increase in wages and related expenses for additional staff to support our increased membership, our expenses related to the Health Insurance Portability and Accountability Act (HIPAA) as well as expenses related to market development activities. Our selling, general and administrative expense ratio to revenue was 11.6% and 13.3% for the second quarter of 2002 and 2001, respectively. The decrease in the ratio was primarily a result of economies of scale and fixed costs being spread over a larger membership base and its related revenue.
 
Interest expense
 
Interest expense was $0.2 million and $0.4 million for each of the three months and six months ended June 30, 2002 and 2001.
 
Provision for income taxes
 
Income tax expense for the second quarter of 2002 was $8.7 million with an effective tax rate of 40.4% as compared to $7.5 million in the second quarter of 2001 with an effective tax rate of 42.7%. Year-to-date, income tax expense was $15.8 million with an effective tax rate of 41.0% compared to $12.4 million with an effective tax rate of 42.0% in 2001. Our effective tax rates decreased in 2002 due to increased levels of investments in tax-advantaged securities.

11


Table of Contents
 
Net income
 
Net income for the second quarter of 2002 rose $2.8 million, or 27.7% to $12.9 million, or $0.60 per diluted share, compared to $10.1 million, or $0.61 per diluted share for the second quarter of 2001. Year-to-date net income was $22.8 million, or $1.07 per diluted share in 2002 compared to $17.2 million, or $1.03 per diluted share in 2001. Diluted earnings per share decreased 1.6% primarily due to an increase of 4,985,000 common shares outstanding from our November 2001 initial public offering.
 
Liquidity and capital resources
 
Our primary sources of liquidity are cash and cash equivalents, short and long-term investments, cash flow from operations and borrowings under our credit facility. As of June 30, 2002, we had cash and cash equivalents of $160.3 million, short and long-term investments of $146.5 million and restricted investments on deposit for licensure of $29.6 million. Total cash and investments as of June 30, 2002 was $336.4 million, a portion of which is restricted by state regulatory requirements. Unrestricted cash as of June 30, 2002 was approximately $120.0 million. As of June 30, 2002, there were no amounts outstanding under our credit facility.
 
On November 9, 2001, we completed our initial public offering of 4,985,000 shares of common stock including an over-allotment issuance of 585,000 shares at a price per share of $17.00. We received net proceeds from the offering of approximately $77.2 million. In conjunction with the offering, all Series A, B, C and D preferred stock in the aggregate was converted into 12,607,880 shares of common stock. We used proceeds from the offering to repay the balance of our long-term debt facility of approximately $4.4 million and to redeem the Series E mandatorily redeemable preferred stock for approximately $13.3 million. In addition, 1,123,823 shares of common stock were issued upon the exercise of all outstanding Series E warrants.
 
Cash from operations was $20.1 million and $31.4 million for the three and six months ended June 30, 2002 compared to $13.4 million and $26.2 million for the three and six months ended June 30, 2001. The increase in cash from operations was primarily due to an increase in net income. As of June 30, 2002, we had working capital and long-term investments of $129.2 million as compared to $122.5 million at December 31, 2001.
 
Cash provided by investing activities was $26.6 million for the three months ended June 30, 2002 and cash used in investing activities was $52.4 million for the six months ended June 30, 2002. For the three and six months ended June 30, 2001, cash used in investing activities was $39.3 million and $31.1 million. Cash provided by investing activities consist primarily of redemptions of held-to-maturity investments of $52.9 million, partially offset by purchases of held-to-maturity investments of $15.7 million. Other investing activities include the purchase of software and property and equipment.
 
Our investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets. As of June 30, 2002, our investment portfolio consisted primarily of fixed-income securities. The average maturity is less than eleven months. We utilize investment vehicles such as municipal bonds, commercial paper, securities of U.S. government backed agencies, and U.S. Treasury instruments. The states in which we operate prescribe the types of instruments in which our subsidiaries may invest their cash. The average portfolio yield as of June 30, 2002 was approximately 2.25% compared to 4.25% as of June 30, 2001.
 
Effective January 1, 2002, we purchased certain assets of MethodistCare, Inc.’s (MethodistCare) Houston, Texas Medicaid line of business for approximately $1.6 million. The assets purchased consisted of MethodistCare’s rights to provide managed care services to its Medicaid members, and certain provider agreements.
 
Effective July 1, 2002, we purchased certain assets of Capital Community Health Plan’s (CCHP) Washington, D.C. Medicaid line of business. The assets purchased consist of CCHP’s rights to provide managed care services to its Medicaid members and certain provider agreements. In June 2002, approximately $6.8 million was placed in escrow for the acquisition.
 
Cash used in financing activities was $0.4 million and $2.5 million for the three and six months ended June 30, 2002 compared to $1.1 million and $1.7 million for the three and six months ended June 30, 2001. Cash used in financing activities consisted primarily of payments on capital leases, proceeds from the exercise of stock options and changes in bank overdrafts.

12


Table of Contents
In July 2002, we expanded the Credit and Guaranty Agreement entered into in November 2001 to include a fourth bank and to increase the revolving credit facility to $75 million from $60 million. The facility is secured by the assets of AMERIGROUP Corporation and by the common stock of its wholly owned subsidiaries.
 
Our subsidiaries are required to maintain minimum statutory capital requirements prescribed by various jurisdictions, including the departments of insurance in each of the states in which we operate. As of June 30, 2002, our subsidiaries were in compliance with all minimum statutory capital requirements. We believe that we will continue to be in compliance with these requirements at least through the end of this year.
 
We believe that internally generated funds and the proceeds from the initial public offering will be sufficient to support continuing operations, capital expenditures and our growth strategy for at least the next 12 months.
 
Recent Accounting Pronouncements
 
In July 2001, Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets (SFAS No. 142), was issued which requires that goodwill and intangible assets with indefinite useful lives no longer be amortized, but instead be tested annually for impairment. We have adopted SFAS No. 142 and have determined that our goodwill and other intangible assets are not impaired.
 
Regulatory Capital and Dividend Restrictions
 
Our operations are conducted through our wholly-owned subsidiaries, which include Health Maintenance Organizations, or HMOs, and one managed care organization, or MCO. HMOs and MCOs are subject to state regulations that, among other things, may require the maintenance of minimum levels of statutory capital, as defined by each state, and restrict the timing, payment and amount of dividends and other distributions that may be paid to their stockholders.
 
The National Association of Insurance Commissioners (NAIC) has adopted rules which, to the extent that they are implemented by the states, will set new minimum capitalization requirements for insurance companies, HMOs and other entities bearing risk for health care coverage. The requirements take the form of risk-based capital rules. The change in rules for insurance companies became effective as of December 31, 1998. The new HMO rules, which may vary from state to state, are currently being considered for adoption. Illinois and Texas adopted various forms of the rules as of December 31, 1999 and 2000, respectively. Maryland adopted risk-based capital rules for MCOs as of December 31, 2001. However, Maryland exempted all MCOs from the rules for the year ended December 31, 2001. New Jersey has not yet adopted risk-based capital. The NAIC’s risk-based capital rules, if adopted by other states in their proposed form, may increase the minimum capital required for our subsidiaries.
 
Item 3.    Quantitative and Qualitative Disclosures About Market Risk
 
As of June 30, 2002, we had short-term investments of $74.5 million and long-term investments of $72.1 million. These investments consist of highly liquid investments with maturities between three and twenty-four months. These investments are subject to interest rate risk and will decrease in value if market rates increase. We have the ability and intent to hold these investments to maturity, and as a result, we would not expect the value of these investments to decline significantly as a result of a sudden change in market interest rates. Declines in interest rates over time may reduce our investment income.

13


Table of Contents
PART II.    OTHER INFORMATION
 
Item 1.    Legal Proceedings
 
We are from time to time the subject matter of, or involved in, legal proceedings. We believe that any liability or loss resulting from such matters will not have a material adverse effect on our financial position or results of operations.
 
Item 2.    Change in Securities and Use of Proceeds
 
 
(a)
 
Change in securities.
 
None.
 
 
(b)
 
Use of Proceeds from Initial Public Offering
 
Our Registration Statement on Form S-1, Registration number 333-37410, relating to our initial public offering, was declared effective by the Securities and Exchange Commission on November 5, 2001. We used proceeds from the offering to repay the balance of our long-term debt facility of approximately $4.4 million and to redeem the Series E mandatorily redeemable preferred stock for approximately $13.3 million. We subsequently used proceeds from the offering to purchase certain assets of MethodistCare, Inc.’s Houston, Texas Medicaid line of business for approximately $1.6 million. In June 2002, we placed approximately $6.8 million into an escrow account for the acquisition of Capital Community Health Plan’s Medicaid line of business in Washington, D.C. The balance of approximately $51.1 million will be used for general corporate purposes, including potential acquisitions.
 
Item 3.    Defaults upon Senior Securities
 
None.
 
Item 4.    Submission of Matters to a Vote of Security Holders
 
We held our annual meeting of stockholders on May 14, 2002. At the meeting, C. Sage Givens and Charles W. Newhall, III were reelected as Class I directors. The vote with respect to each nominee is set forth below:
 
    
Total Vote For Each Director

    
Total Vote Withheld From Each Director

Ms. Givens
  
17,318,142
    
50,800
Mr. Newhall
  
17,318,142
    
50,800
 
Additional directors of the company whose terms of office continued after the meeting are Carlos A. Ferrer, William J. McBride, Jeffrey L. McWaters and Uwe E. Reinhardt, Ph.D.
 
Our stockholders ratified our appointment of KPMG LLP to serve as our independent auditors for the 2002 fiscal year. The appointment was approved by a vote of 17,285,342 for, 50,800 shares against and 32,800 shares abstaining.
 
Item 5.    Other Information
 
None.

14


Table of Contents
Item 6.    Exhibits and Reports on Form 8-K
 
a.    Exhibits:
 
Exhibit
Number

    
Description

3.1
*
  
Form of Amended and Restated Certificate of Incorporation of the Company.
3.2
*
  
Form of By-Laws of the Company.
3.3
*
  
Form of share certificate for common stock.
3.4
*
  
AMERIGROUP Corporation Second Restated Investor Rights Agreement, dated July 28, 1998.
3.5
*
  
Silicon Valley Registration Rights Agreement, entered into as of May 15, 1998.
3.6
*
  
Stock Restriction and Registration Rights Agreement, between AMERIGROUP Corporation and Prudential Health Care Plan, Inc.
3.7
*
  
Form of warrant issued in connection with the sale of Series E Redeemable Preferred Stock.
3.8
*
  
Common Stock Purchase Warrant Issued to Silicon Valley Bank, dated May 15, 1998.
10.1
*
  
1999 Contract for Services between the Texas Department of Health (“TDH” ) and HMO (Harris Service Area), dated August 9, 1999.
10.2
*
  
1999 Contract For Services between the TDH and HMO (Tarrant Service Area), dated August 9, 1999.
10.3
*
  
1999 Contract For Services between the TDH and HMO (Harris County Service Area STAR+PLUS Contract).
10.4
*
  
2000 Contract For Services between TDH and HMO Dallas Service Area (replaces prior exhibit 10.4).
10.5
*
  
Children’s Health Insurance Program Agreement for the Provision of Health Care Services between the Texas Department of Health and Human Services Commission and AMERICAID Texas, Inc., d/b/a Amerikids, dated January 19, 2000, as amended (replaces prior exhibit 10.5).
10.6
*
  
Contract between State of New Jersey, Department of Human Services, Division of Medical Assistance and Health Services and [Americaid New Jersey, Inc.], Contractor (replaces prior exhibit 10.6).
10.7
*
  
State of Illinois, Department of Public Aid Contract for Furnishing Health Services by a Health Maintenance Organization, dated April 1, 2000.
10.8
*
  
Managed Care Organization HealthChoice Provider Agreement, dated as of January 1, 2000.
10.9
*
  
District of Columbia Medicaid Managed Care Program, Department of Health, Prepaid, Capital Risk Contract.
10.10
*
  
1994 Stock Plan.
10.11
*
  
Form of 2000 Equity Incentive Plan.
10.12
*
  
Form of Employee Stock Purchase Plan.
10.13
*
  
Form of 2000 Cash Incentive Plan.
10.14
*
  
Second Amended and Restated Employment Agreement of Jeffrey L. McWaters, dated October 2, 2000 (replaces prior exhibit 10.14).
10.15
*
  
Employment Agreement of Lorenzo Childress, Jr., M.D.
10.16
*
  
Form of Officer and Director Indemnification Agreement.
10.17
*
  
CCPN and HMO Medicaid Agreement By and Between Americaid Texas Inc., d/b/a Americaid Community Care, and Cook Children’s Physician Network, A Texas 5.01 Non-profit Corporation, dated as of October 9, 1997, as amended.

15


Table of Contents
Exhibit
Number

    
Description

10.18
*
  
Third Medical Assistance Medical Services Agreement between Prudential Health Care Plan, Inc. and Johns Hopkins Medical Services Corporation, dated August 2, 1996, assigned to the Company pursuant to the Amendment and Assignment of Third Medical Assistance Medical Service Agreement, as of April 30, 1999.
10.19
*
  
Loan and Security Agreement, between AMERIGROUP Corporation, as borrower, and the Financial Institutions Party Thereto From Time to Time, as Lender and Fleet Capital Corporation, as Agent, dated November 9, 1999.
10.20
*
  
Amendment, dated September 1, 2001, to the 1999 Contract for Services between TDH and HMO (Harris County Service Area, STAR+PLUS Contract).
10.21
**
  
Credit and Guaranty Agreement, between AMERIGROUP Corporation, as borrower and Bank of America N.A., administrative agent, UBS Warburg LLC and CIBC World Markets Corp., as lenders, dated December 14, 2001.
10.22
***
  
District of Columbia Healthy Families Program, Department of Health, Prepaid, Capital Risk Contract dated April 9, 2002, together with amendments.
10.23
 
  
Lender Joinder Agreement, by and among AMERIGROUP Corporation, Wachovia Bank, National Association, and the Securities named therein, dated as of June 28, 2002.
99.1
 
  
Certification of Chief Executive Officer and Chief Financial Officer, dated August 2, 2002

*
 
Previously filed as an exhibit to Registration Statement No. 333-3740 on Form S-1, which was declared effective by the Securities and Exchange Commission on November 5, 2001, and incorporated herein by reference.
 
**
 
Previously filed as an exhibit to the Annual Report on Form 10-K filed on March 12, 2002.
 
***
 
Previously filed as an exhibit to the Quarterly Report on Form 10-Q filed on May 13, 2002.
 
b.    Reports on Form 8-K
 
None.

16


Table of Contents
SIGNATURE
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized on the 2nd day of August, 2002.
 
AMERIGROUP CORPORATION
By:
 
/s/    JEFFREY L. MCWATERS        

   
Chairman and Chief
Executive Officer
 
 
By:
 
/s/    SCOTT M. TABAKIN        

   
Senior Vice President,
Chief Financial Officer
(Principal Financial and Accounting Officer)
 

17